Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.24%
#2 aelf aelf +23.74%
#3 Decred Decred +12.08%
#4 Bitway Bitway +10.57%
#5 AtomOne AtomOne +10.54%
#6 TRIA TRIA +9.39%
#7 Pons Pons +8.39%
#8 Wibx Wibx +8.12%
#9 Status Status +7.87%
#10 Starpower Starpower +7.61%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
Rank in Stocks #30387
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Share Price
$1.25
Last synced: 2026-08-18
Market Cap
$17.05M
Change (1 day)
-1.50%
Change (1 year)
-22.24%
Country
FR
Trade Aelis Farma S.A. (AELIS)

Category

Healthcare
Number of shares outstanding for Aelis Farma S.A. (AELIS)
Number of shares outstanding as of August 2026: 0
According to Aelis Farma S.A. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Aelis Farma S.A. (AELIS) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE